Literature DB >> 10381911

Epithelial permeability to proteins in the noninflamed ileum of Crohn's disease?

J D Söderholm1, K H Peterson, G Olaison, L E Franzén, B Weström, K E Magnusson, R Sjödahl.   

Abstract

BACKGROUND & AIMS: Crohn's disease (CD) is associated with a disturbed intestinal barrier. Permeability studies have focused on inert molecules, but little is known about transepithelial transport of macromolecules with antigenic potential in humans. The aim of this study was to quantify permeation and to characterize passage routes for macromolecules in ileal mucosa in CD.
METHODS: Noninflamed and inflamed ileal mucosa specimens from patients with CD (n = 12) and ileal specimens from patients with colon cancer (n = 7) were studied regarding transmucosal permeation of ovalbumin, dextran (mol wt, 40,000), and 51Cr-EDTA for 90 minutes in vitro in Ussing chambers. Transepithelial passage routes for fluorescent ovalbumin and dextran 40,000 were investigated by confocal microscopy.
RESULTS: Noninflamed ileum from CD patients showed increased permeation of ovalbumin compared with ileum from colon cancer patients (P < 0.05). Dextran permeation was equal in the three groups, whereas 51Cr-EDTA permeability was increased in inflamed ileum. Ovalbumin passed both transcellularly and paracellularly, but dextran followed a strictly paracellular route. Both markers were subsequently endocytosed by cells of the lamina propria.
CONCLUSIONS: Noninflamed ileal mucosa from patients with CD shows increased epithelial permeability to ovalbumin, probably by augmented transcytosis. This increase in antigen load to the lamina propria could be an initiating pathogenic event in CD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381911     DOI: 10.1016/s0016-5085(99)70551-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  48 in total

1.  Apically exposed, tight junction-associated beta1-integrins allow binding and YopE-mediated perturbation of epithelial barriers by wild-type Yersinia bacteria.

Authors:  F Tafazoli; A Holmström; A Forsberg; K E Magnusson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

2.  Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.

Authors:  T Kucharzik; S V Walsh; J Chen; C A Parkos; A Nusrat
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

3.  A coculture model mimicking the intestinal mucosa reveals a regulatory role for myofibroblasts in immune-mediated barrier disruption.

Authors:  L E M Willemsen; C C H M Schreurs; H Kroes; E J Spillenaar Bilgen; S J H Van Deventer; E A F Van Tol
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

Review 4.  Increased gut permeability in Crohn's disease: is TNF the link?

Authors:  P R Gibson
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

Review 5.  Regulation of intestinal epithelial permeability by tight junctions.

Authors:  Takuya Suzuki
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

6.  Mycobacterium avium subspecies paratuberculosis infection in cases of irritable bowel syndrome and comparison with Crohn's disease and Johne's disease: common neural and immune pathogenicities.

Authors:  Antonio M Scanu; Tim J Bull; Sara Cannas; Jeremy D Sanderson; Leonardo A Sechi; Giuseppe Dettori; Stefania Zanetti; John Hermon-Taylor
Journal:  J Clin Microbiol       Date:  2007-10-03       Impact factor: 5.948

7.  Role of probiotics in correcting abnormalities of colonic flora induced by stress.

Authors:  Helene Eutamene; Lionel Bueno
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

Review 8.  Role of the intestinal barrier in inflammatory bowel disease.

Authors:  Mike G Laukoetter; Porfirio Nava; Asma Nusrat
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

9.  Enterocyte cytoskeleton changes are crucial for enhanced translocation of nonpathogenic Escherichia coli across metabolically stressed gut epithelia.

Authors:  Aisha Nazli; Arthur Wang; Oren Steen; David Prescott; Jun Lu; Mary H Perdue; Johan D Söderholm; Philip M Sherman; Derek M McKay
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

10.  Probiotics, Irritable Bowel Syndrome, and Inflammatory Bowel Disease.

Authors:  Martin H. Floch
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.